Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Aβo-PrPC binding and downstream pathways.
Grayson JD, Baumgartner MP, Santos Souza CD, Dawes SJ, El Idrissi IG, Louth JC, Stimpson S, Mead E, Dunbar C, Wolak J, Sharman G, Evans D, Zhuravleva A, Roldan MS, Colabufo NA, Ning K, Garwood C, Thomas JA, Partridge BM, de la Vega de Leon A, Gillet VJ, Rauter AP, Chen B.
Grayson JD, et al. Among authors: evans d.
Chem Sci. 2021 Feb 1;12(10):3768-3785. doi: 10.1039/d0sc04769d.
Chem Sci. 2021.
PMID: 34163650
Free PMC article.